Concepedia

Magnus Munck af Rosenschöld

MM

Statistics

Publications

1

Citations

23

H-Index

1

Active since

2019

Affiliations

Orexo (Sweden)(Current)

Magnus Munck af Rosenschöld is an author at Orexo (Sweden) specializing in lead compound screening, pharmacology, and bronchodilator therapy.

Publications per year

2019–2019

1

Publications

1

Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1<i>S</i>,2<i>S</i>)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma

Magnus Munck af Rosenschöld, Petra Johannesson, Antonios Nikitidis et al. · Journal of Medicinal Chemistry · 2019 · 23 citations · Full text

, , +12

1–1 of 1